Scott Jenkins
14Patents
8h-index
34Co-inventors
68Inventor score
Filing activity: Feb 20, 1996 → May 18, 2011
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7419984B2 | Pyrimidines and uses thereof | Chemistry; Metallurgy | 23 | Expired |
| US7910577B2 | Injectable nanoparticulate olanzapine formulations | Emerging Cross-Sectional Technologies | 21 | Active |
| US8158153B2 | Nanoparticulate bisphosphonate compositions | Human Necessities | 15 | Active |
| US8119163B2 | Nanoparticulate and controlled release compositions comprising cefditoren | Human Necessities | 12 | Active |
| US9012511B2 | Nanoparticulate cinacalcet compositions | Human Necessities | 10 | Active |
| US8003127B2 | Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof | Emerging Cross-Sectional Technologies | 10 | Active |
| US7291616B2 | Aryl triazines as LPAAT-β inhibitors and uses thereof | Chemistry; Metallurgy | 9 | Expired |
| US5587481A | Preparation of (S)-decahydroisoquinoline-3-carboxylic acid t-butylamide | Human Necessities | 8 | Expired |
| US7618968B2 | Aryl triazines as LPAAT-β inhibitors and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US7411002B2 | Polycationic sulfonamides and use thereof | Chemistry; Metallurgy | 6 | Active |
| US7825087B2 | Nanoparticulate and controlled release compositions comprising cyclosporine | Human Necessities | 2 | Active |
| US8309133B2 | Nanoparticulate quinazoline derivative formulations | Human Necessities | 2 | Active |
| US8367112B2 | Nanoparticulate carverdilol formulations | Human Necessities | 2 | Active |
| US7759382B2 | Acylated amino acid amidyl pyrazoles and related compounds | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.